How many employees does RadioClash have?

As of Sep 30, 2026, the latest employee count at RadioClash is 6.

Is RadioClash a funded company?

RadioClash is a funded company, having raised a total of $1.41M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 28, 2024.

When was the latest funding round of RadioClash?

RadioClash's latest funding was a $***** Seed round on Dec 09, 2025, with participation from 0 investor.

Where does RadioClash rank among its competitors?

RadioClash ranks 11th amongst 19 active competitors, of which 5 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was QV Bioelectronics, which secured $6.05M in Jan, 2026.

Who are the top competitors of RadioClash?

RadioClash's top competitors include Novocure, QV Bioelectronics and ChemoTech. Among them, QV Bioelectronics secured the most recent funding round in January, 2026.

RadioClash - 2026 Company Profile, Funding & Competitors

Company Details

Provider of curated audio mixes and related media content services. It offers a platform for listening to diverse audio content. The company focuses on delivering a range of curated mixes.

Key Metrics

Stage

Seed

Total Funding

$1.41M in 2 rounds

Latest Funding Round

Seed, Dec 09, 2025, $*****

Investors

ABGD Ventures

Ranked

11^th among 19 active competitors

Employee Count

6 as on Sep 30, 2026

Similar Companies

Novocure & 19 more

View RadioClash's full profile

RadioClash has raised a total funding of $1.41M over 2 rounds. Its first funding round was on Oct 28, 2024. RadioClash has 1 institutional investor.

Here is the list of recent funding rounds of RadioClash:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 09, 2025	7555290	Seed	3715311	6029053	7270096	9003620
Oct 28, 2024	9822860	Seed	3256731	3970645	3957917	4659609

Access funding benchmarks and valuations. Sign up today!

View details of RadioClash's funding rounds and investors

RadioClash's employee count trend

RadioClash has 6 employees as of Sep 26. Here is RadioClash's employee count trend over the years:

Uncover RadioClash's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of RadioClash include Novocure, QV Bioelectronics and ChemoTech. Here is the list of Top 10 competitors of RadioClash, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novocure 2000, Haifa (Israel), Public	Developer of therapeutics to treat solid tumours	$10M	Johnson & Johnson Innovation – JJDC, Pfizer Venture Investments ... & 13 others	65/100
2nd	QV Bioelectronics 2019, Manchester (United Kingdom), Series A	Manufacturer of electrotherapy devices for treating brain tumors	$9.63M	SOSV, PXN Ventures & 18 others	55/100
3rd	ChemoTech 2015, Lund (Sweden), Public	Developer of electroporation devices for the treatment of cancer	-	EIC Fund, Europa	46/100
4th	Autem Therapeutics 2022, Hanover (United States), Series A	Developer of bioelectric technology-based device for cancer	$11.5M	Zentynel, Spectra Investments & 1 others	43/100
5th	New Phase 2013, Petah Tikva (Israel), Funding Raised	Provider of nanoparticle based tumor-targeting molecules for cancer treatment	-	Real-Life Innovations	34/100
6th	LifeBridge Innovations 2016, Orlando (United States), Series A	Developer of electric connection-based device to treat human tissues and cure tumor-related diseases	$3.38M	-	29/100
7th	Gradient Medical 2020, Raleigh (United States), Funding Raised	Developer of pulsed electric field therapies for tumors	-	America’s Seed Fund, HHS	26/100
8th	Autem Medical 2017, Hanover (United States), Unfunded	Provider of non-invasive device for cancer patient	-	Venturance	23/100
9th	LaZure Scientific 2006, Issaquah (United States), Deadpooled	Low dose alternating current to heat and preferentially destroy tumour cells	$5.16M	-	22/100
10th	CancerCell 2018, Los Angeles (United States), Seed	Developer of personalized bioelectric cancer tumor eradication therapy	-	Leonhardt Ventures	22/100
11th	RadioClash Seed	Provider of curated audio mixes and related media content services	$1.41M	ABGD Ventures	21/100